Pharma cos may post soft Q3, to lean on low baseĀ 
Jan 13, 2018 - Economic Times

The pharmaceutical sector may have hit a soft patch, which is likely to post a subdued bottom line for the quarter to December 2017. However, revenue growth could be in for some traction because of a low base effect in the wake of demonetisation. ICICI Securities expects that Ebitda margin of companies under its coverage may decline as much as 280 basis points on year, pressured … (continue reading)

Would you like to track this news?

Click one of the buttons below or search.

Advanced Options | Search Tips